Drug Shortage Report for TARO-VENLAFAXINE XR
Report ID | 93294 |
Drug Identification Number | 02380072 |
Brand name | RAN-VENLAFAXINE XR |
Common or Proper name | RAN-VENLAFAXINE XR |
Company Name | SUN PHARMA CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | VENLAFAXINE |
Strength(s) | 37.5MG |
Dosage form(s) | CAPSULE (EXTENDED RELEASE) |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | N06AX |
ATC description | ANTIDEPRESSANTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2019-09-04 |
Estimated end date | 2020-01-31 |
Actual end date | 2020-01-17 |
Shortage status | Resolved |
Updated date | 2020-01-20 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 126 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2020-01-20 | French | Compare |
v7 | 2020-01-20 | English | Compare |
v6 | 2020-01-04 | French | Compare |
v5 | 2020-01-04 | English | Compare |
v4 | 2019-10-04 | French | Compare |
v3 | 2019-10-04 | English | Compare |
v2 | 2019-09-09 | French | Compare |
v1 | 2019-09-09 | English | Compare |
Showing 1 to 8 of 8